Cost-effectiveness of therapeutic interventions in schizophrenia

• Autores: Lina Díaz-Castro, Héctor Cabello-Rangel, Armando Arredondo López, C. Pineda Antúnez, Eduardo A. Madrigal de León
• Localización: European journal of psychiatry, ISSN 0213-6163, Vol. 31, Nº 1, 2017, págs. 11-16
• Idioma: inglés
• DOI: 10.1016/j.ejpsy.2016.12.006
• Texto completo no disponible (Saber más ...)
• Resumen

  • Background:

    Various studies have reported that a decision-tree analysis is useful to evaluate different treatment strategies in real clinical practice.

• Referencias bibliográficas
  • J. van Os, S. Kapur Schizophrenia Lancet, 374 (2009), pp. 635-645
  • E. Caraveo-Anduaga, L. Bermudez. Psychiatric disorders and substance abuse in México: epidemiological perspective. Salud Mental, 25 (2002),...
  • R.B. Bera. Patient outcomes within schizophrenia treatment: a look at the role of long acting injectable antipsychotics.J Clin Psychiatry,...
  • J.P. Lacro, L.B. Dunn, C.R. Dolder, S.G. Leckband, D.V. Jeste. Prevalence and risk factors for medication non-adherence in patients with schizophrenia:...
  • P. Thieda, S. Beard, A. Ritchter, J. Kane. An economic review of adherence with medication therapy in the treatment of schizophrenia. Psychiatr...
  • B.L. Svarstad, T.I. Shireman, J.K. Sweeney. Using drug claims data to assess the relationship of medication adherence with hospitalization...
  • J.A. Lieberman, T.S. Strop, P.J. McEvoy, M.S. Swartz, R.A. Rosenheck, D.O. Perkins, et al. Effectiveness of antipsychotic drugs in patients...
  • P.J. Weiden, C. Kozma, A. Grogg, J. Locklear. Partial compliance and risk of rehospitalization among california medicaid patients with schizophrenia....
  • W.M. Glazer, L. Ereshefsky. A pharmacoeconomic model of outpatient antipsychotic therapy in “revolving door” schizophrenic patients. J Clin...
  • C.S. Palmer, D.A. Revicki, L.A. Genduso, S.H. Hamilton, R.E. Brown. A cost-effectiveness clinical decision analysis model for schizophrenia....
  • C.S. Palmer, E. Brunner, L. Ruiz-Flores, F. Paez-Agraz, D.A. Revicki. A cost-effectiveness clinical decision analysis model for treatment...
  • M. Stuhec, D. Petrica, J. Toni. The cost and effects of atypical antipsychotic agents in patients with schizophrenia in slovenia: a cost effectiveness...
  • O. Gómez-Dantés, S. Sesma, V.M. Becerril, F.M. Knaul, H. Arreola, J. Frenk. The health system of México. Salud Publica Mex, 53 (Suppl. 2)...
  • Ministry of Health. Specific action program mental health care, Mexico (2008)
  • R. Rascón, A. Arredondo, L. Tirado, M. López. An approximation of the cost of mental illness in México: depression and schizophrenia. Salud...
  • H. Cabello, L. Díaz, A. Arredondo. Cost effectiveness of interventions for schizophrenia in México. Salud Mental, 34 (2011), pp. 95-102
  • M. Obradovic, M. Mrhar, M. Kos. Cost-effectiveness of antypsychotics for outpatients whith chronic schizophrenia. Int J Clin Pract, 61 (2007),...
  • T.R. Einarson, H. Pudas, R. Zilbershtein, R. Jensen, C. Vicente, C. Piwko, et al. Cost-effectivennes analysis of atypical long-acting antipsychotics...
  • D. Koczerginski, C. Arshoff. Hospital resource use by patients with schizophrenia: reduction after conversion from oral treatment to risperidone...
  • M.C. Lara-Muñoz, R. Robles-García, R. Orozco, M.T. Saltiljeral-Méndez, M.E. Medina-Mora, D. Chisholm. Cost effectiveness of treatment for...